Forte Biosciences, Inc. (FBRX)
- Previous Close
7.07 - Open
7.00 - Bid --
- Ask --
- Day's Range
6.60 - 7.18 - 52 Week Range
6.50 - 21.25 - Volume
9,697 - Avg. Volume
5,451 - Market Cap (intraday)
9.827M - Beta (5Y Monthly) 1.45
- PE Ratio (TTM)
-- - EPS (TTM)
-17.25 - Earnings Date Nov 11, 2024 - Nov 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
112.50
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
www.fortebiorx.comRecent News: FBRX
View MorePerformance Overview: FBRX
Trailing total returns as of 9/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FBRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FBRX
View MoreValuation Measures
Market Cap
10.35M
Enterprise Value
-14.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.61
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-81.25%
Return on Equity (ttm)
-170.91%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-35.76M
Diluted EPS (ttm)
-17.25
Balance Sheet and Cash Flow
Total Cash (mrq)
24.5M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-18.24M